| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-88 |
Sentence |
denotes |
A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase. |
| T1 |
0-88 |
Sentence |
denotes |
A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase. |
| TextSentencer_T2 |
89-357 |
Sentence |
denotes |
Palmitoyl-CoA dehydrogenase activity in skin fibroblasts from seven patients with unidentified defects of fatty acid oxidation was measured in the presence and absence of antibodies against medium-chain, long-chain, and very-long-chain acyl-CoA dehydrogenases (VLCAD). |
| T2 |
89-357 |
Sentence |
denotes |
Palmitoyl-CoA dehydrogenase activity in skin fibroblasts from seven patients with unidentified defects of fatty acid oxidation was measured in the presence and absence of antibodies against medium-chain, long-chain, and very-long-chain acyl-CoA dehydrogenases (VLCAD). |
| TextSentencer_T3 |
358-603 |
Sentence |
denotes |
Two of the patients, 4-5 month old boys, were found to have a novel disease, VLCAD deficiency, as judged from the results of very low palmitoyl-CoA dehydrogenase activity and the lack of immunoreactivity toward antibody raised to purified VLCAD. |
| T3 |
358-603 |
Sentence |
denotes |
Two of the patients, 4-5 month old boys, were found to have a novel disease, VLCAD deficiency, as judged from the results of very low palmitoyl-CoA dehydrogenase activity and the lack of immunoreactivity toward antibody raised to purified VLCAD. |
